Literature DB >> 21955364

Quantifying cannabis use with the timeline followback approach: a psychometric evaluation.

Melissa M Norberg1, Jennifer Mackenzie, Jan Copeland.   

Abstract

BACKGROUND: In the absence of a standardized cannabis unit, self-report instruments are inadequate for accurate quantification of cannabis use. The study extends the feasibility of using a cannabis substitute to reliably and validly measure quantity of cannabis use.
METHOD: Ninety-eight adult Australian cannabis users (M age=27.98, SD=11.10; 65.31% male) completed a 90-day Timeline Followback interview regarding their cannabis use, utilizing the cannabis substitute Marijuanilla to report on quantity of use. Ninety-two of these individuals completed the interview at two time-points, and 56 of these participants had collaterals corroborate their cannabis use reports.
RESULTS: Inter-rater reliability was excellent, while test-retest reliability was good to excellent. Intra-class correlation coefficients between participant and collateral reports, while similar to previous research, were unacceptable. Quantity of cannabis use statistically significantly added to frequency of use in predicting cannabis problems and dependence severity. Concurrent and discriminant validity were established with single-item and positive impression management measures, respectively. In addition, Marijuanilla appeared similar to one specimen of street seized cannabis, but not to two others. Importantly, participants' cravings to use cannabis did not increase as a result of using the cannabis substitute to report on their cannabis use.
CONCLUSIONS: These data suggest that utilizing Marijuanilla to facilitate the reporting of grams of cannabis use may be reliable and valid; however, such comprehensive assessment may only be necessary for clinical trials and epidemiological studies, which rely on precise estimates of cannabis use. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21955364     DOI: 10.1016/j.drugalcdep.2011.09.007

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  37 in total

1.  Recent Self-Reported Cannabis Use Is Associated With the Biometrics of Delta-9-Tetrahydrocannabinol.

Authors:  Matthew J Smith; Eva C Alden; Amy A Herrold; Andrea Roberts; Dan Stern; Joseph Jones; Allan Barnes; Kailyn P O'Connor; Marilyn A Huestis; Hans C Breiter
Journal:  J Stud Alcohol Drugs       Date:  2018-05       Impact factor: 2.582

2.  Using Composite Scores to Summarize Adolescent Sexual Risk Behavior: Current State of the Science and Recommendations.

Authors:  David H Barker; Lori A J Scott-Sheldon; Daniel Gittins Stone; Larry K Brown
Journal:  Arch Sex Behav       Date:  2019-08-19

3.  Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.

Authors:  Dustin C Lee; Nicolas J Schlienz; Erica N Peters; Robert H Dworkin; Dennis C Turk; Eric C Strain; Ryan Vandrey
Journal:  Drug Alcohol Depend       Date:  2018-11-15       Impact factor: 4.492

Review 4.  The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.

Authors:  Mallory J E Loflin; Brian D Kiluk; Marilyn A Huestis; Will M Aklin; Alan J Budney; Kathleen M Carroll; Deepak Cyril D'Souza; Robert H Dworkin; Kevin M Gray; Deborah S Hasin; Dustin C Lee; Bernard Le Foll; Frances R Levin; Joshua A Lile; Barbara J Mason; Aimee L McRae-Clark; Ivan Montoya; Erica N Peters; Tatiana Ramey; Dennis C Turk; Ryan Vandrey; Roger D Weiss; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2020-04-26       Impact factor: 4.492

5.  Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study.

Authors:  Robert Miranda; Hayley Treloar; Alexander Blanchard; Alicia Justus; Peter M Monti; Thomas Chun; Robert Swift; Jennifer W Tidey; Chad J Gwaltney
Journal:  Addict Biol       Date:  2016-01-11       Impact factor: 4.280

Review 6.  Clinical correlates of co-occurring cannabis and tobacco use: a systematic review.

Authors:  Erica N Peters; Alan J Budney; Kathleen M Carroll
Journal:  Addiction       Date:  2012-04-17       Impact factor: 6.526

7.  Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users.

Authors:  Evan S Herrmann; Elise M Weerts; Ryan Vandrey
Journal:  Exp Clin Psychopharmacol       Date:  2015-10-12       Impact factor: 3.157

8.  What's the influence of social interactions on substance use and treatment initiation? A prospective analysis among substance-using probationers.

Authors:  Stephanie A Spohr; Melvin D Livingston; Faye S Taxman; Scott T Walters
Journal:  Addict Behav       Date:  2018-10-01       Impact factor: 3.913

Review 9.  Gambling and Cannabis Use: Clinical and Policy Implications.

Authors:  Ken C Winters; James P Whelan
Journal:  J Gambl Stud       Date:  2020-03

10.  The Effects of Lithium Carbonate Supplemented with Nitrazepam on Sleep Disturbance during Cannabis Abstinence.

Authors:  David J Allsop; Delwyn J Bartlett; Jennifer Johnston; David Helliwell; Adam Winstock; Iain S McGregor; Nicholas Lintzeris
Journal:  J Clin Sleep Med       Date:  2015-10-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.